Compare PTCT & CPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PTCT | CPA |
|---|---|---|
| Founded | 1998 | 1947 |
| Country | United States | Panama |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Air Freight/Delivery Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 5.5B |
| IPO Year | 2006 | 2005 |
| Metric | PTCT | CPA |
|---|---|---|
| Price | $69.04 | $116.69 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 10 |
| Target Price | $80.65 | ★ $159.40 |
| AVG Volume (30 Days) | ★ 733.3K | 476.2K |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 5.80% |
| EPS Growth | ★ 264.48 | N/A |
| EPS | ★ 7.78 | N/A |
| Revenue | ★ $264,734,000.00 | N/A |
| Revenue This Year | N/A | $15.51 |
| Revenue Next Year | $17.70 | $7.25 |
| P/E Ratio | ★ $8.75 | $9.05 |
| Revenue Growth | ★ 36.19 | N/A |
| 52 Week Low | $35.95 | $89.47 |
| 52 Week High | $87.50 | $156.41 |
| Indicator | PTCT | CPA |
|---|---|---|
| Relative Strength Index (RSI) | 48.31 | 45.50 |
| Support Level | $64.00 | $110.92 |
| Resistance Level | $69.23 | $122.76 |
| Average True Range (ATR) | 2.38 | 4.27 |
| MACD | -0.33 | 0.22 |
| Stochastic Oscillator | 25.12 | 9.83 |
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
Copa Holdings SA is a provider of airline passenger and cargo services through its subsidiaries. The company operates through the air transportation segment. It offers international air transportation for passengers, cargo, and mail, operating from its Panama City hub in the Republic of Panama, and domestic and international air transportation for passengers, cargo, and mail with a point-to-point route network through Copa Colombia, a Colombian air carrier. The company's geographical segments are North America, South America, Central America, and the Caribbean. It derives the maximum revenue from North America.